AK135NadunolimabCAN04CIPNchronic neuropathic painchemotherapy
… relief.Conclusions As a potential chemotherapy companion drug, AK135 potently targets IL-1RAP to block IL-1/IL-33/IL-36-driven infla…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 7,621–7,680 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
angiotensin II1angiotensin II inhibitors1angiotensin II receptor blocker1angiotensin converting enzyme (ACE) inhibitor1angiotensin converting enzyme inhibitors-angiotensin II receptor blockers1anifrolumabAbstract1anlotinib-induced1antacid1anthelmintic medication1anthelmintics1anti PD-11anti-4-1BB1anti-B7-H3 antibody‒drug conjugate1anti-BAFF1anti-CD38 mAb1anti-CD38 monoclonal antibodies1anti-CD401anti-CD40 agonist antibody1anti-CD47 monoclonal antibody1anti-CGRP monoclonal antibodies1anti-CTLA-4 antibody1anti-CTLA-4 mAb1anti-CTLA4 antibody1anti-HER2 antibody-drug conjugates1anti-Ly6G1anti-MDA5 antibody1anti-Mullerian Hormone1anti-Müllerian hormone1anti-OA pharmacological agents1anti-OX401anti-PD-(L)1-based1anti-PD-1 ICB1anti-PD-L1 avelumab1anti-Parkinson’s drugs1anti-Sjögren’s syndrome antigen A1anti-TIM-31anti-Th/To-positive1anti-VEGF agents1anti-VEGFR21anti-anginal medication1anti-cancer compounds1anti-cytotoxic T lymphocyte-associated antigen-4 immune checkpoint inhibitors1anti-diabetic agents1anti-fibrotic medications1anti-histamines1anti-hypertensive drugs1anti-infectious agents1anti-inflammatory drugs1anti-inflammatory reliever1anti-interferon1anti-oestrogen medications1anti-pan γδ x CD1231anti-pan γδ x CD123 bispecific antibody1anti-programmed cell death protein 11anti-programmed cell death protein 1 (PD1)1anti-programmed cell death protein-1/programmed death-ligand 11anti-programmed death (ligand) 11anti-programmed death-ligand 1 (PD-(L)1)1anti-programmed death-ligand 1 (PD-L1)1anti-programmed death-ligand 1 antibodies1
Articles mentioning drugs
10,506 articles · page 71 of 876EVM14
… the antigen-expressing tumor cells in mice. The combination of EVM14 with ICIs significantly enhanced the anti-tumor activity. EVM14…
CytoChexTransfixsodium heparin
…days at 4°C) but is not optimal for storage longer than 3 days. CytoChex underperforms in preserving key immune cell populations. TokuKi…
HCW11-006HCW11-006-treatedBCGNSG mouse modelbladder cancer modelEG7-OVA tumor model
…unctionality, and synergizes with immune checkpoint inhibitors. HCW11-006 represents a promising immunotherapeutic agent capable of induc…
AC484ABBV-CLS-484solid tumors
…ctivity of a variety of immune subsets. These data suggest that AC484 therapy can be deployed in the clinic to markedly enhance adopt…
Afamitresgene autoleucelafami-celadvanced synovial sarcomaAdaptimmune
…044768.Reference D’Angelo SP, Araujo DM, Abdul Razak AR, et al. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma…
INCB177054INCB171138MC38CT26
… cells from the tumor and spleen in the MC38 model treated with INCB177054 ± anti-PD1 using paired scRNA-seq and single cell T-cell recept…
rituximabtocilizumabprednisoneMemorial Sloan Kettering Cancer Center Institutional Review Boardbullous pemphigoidColumbia University Institutional Review Boardarthritisosteoporosis
…atients were enrolled based on published data supporting use of rituximab or tocilizumab. Each arm aimed to enroll 15 patients. Primary e…
HM16390pembrolizumabvascular leak syndromecytokine release syndromeArm AArm B
…n while modulating immunosuppressive regulatory T cell (T reg). HM16390 is a novel, long-acting IL-2 analog engineered with precise bin…
IMA203cyclophosphamidemRNA-4203PRAMEfludarabinesynovial sarcomaImmatics US, Inc.SSadvanced cutaneous melanoma
…ed by ORR, DOR, DCR, and PFS. Additionally, pharmacokinetics of IMA203 transgene levels in peripheral blood will be evaluated. The tri…
BAY2965501BAY2862789NCT05858164cancer
…rmed on a subset of patients (n=>10), including the addition of BAY2965501, demonstrated synergistic elevation in IFNγ and IL2 production …
CHS-114toripalimabhead and neck squamous cell carcinomaadvanced solid tumorsHNSCC
…ed favorable CHS-114 mediated anti-tumor remodeling.Conclusions CHS-114 administration to HNSCC patients demonstrates selective depleti…